GlassScriptPhysician profile
Jonathan Pajouh
NPI 1316437759
$14,464.88
in general payments reported to CMS, 2019-2025
34 companies · $1,809 in 2025
The $1,809 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,130 · 2020: $1,021 · 2021: $1,436 · 2022: $2,566 · 2023: $692 · 2024: $1,811 · 2025: $1,809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,358 · Education: $1,164 · Long Term Medical Supply Or Device Loan: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,358.02 |
| Education | $1,164.19 |
| Long Term Medical Supply Or Device Loan | $789.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $8,404.78 | 2019-2022 | |
| Stryker Corporation | $3,433.26 | 2021-2025 | Prostep Mica, Infinity, Prostep |
| Integra Lifesciences Corporation | $789.18 | 2025 | Cytal |
| Treace Medical Concepts, INC. | $321.98 | 2022-2025 | |
| Smith+Nephew, INC. | $236.15 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Stravix Pl, Grafix Pl |
| Bone Support INC. | $182.87 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Organogenesis INC. | $137.32 | 2023-2024 | Puraply, Novachor |
| Orthofix Medical, INC. | $130.51 | 2021-2025 | Physio-Stim |
| Exact Sciences Corporation | $60.40 | 2025 | Cologuard Collection Kit |
| Linvatec Corporation | $59.04 | 2020 | |
| Amniox Medical, INC. | $57.83 | 2020 | |
| Paratek Pharmaceuticals, INC. | $56.02 | 2022-2025 | Nuzyra |
| Trimed, INC. | $48.46 | 2023 | |
| Mimedx Group, INC. | $48.40 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $47.24 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $47.12 | 2024-2025 | Proclaim |
| Medtronic, INC. | $45.02 | 2022-2023 | Intellis Adaptivestim |
| Novo Nordisk INC | $44.61 | 2023-2025 | Wegovy, Ozempic |
| Convatec INC. | $34.16 | 2023 | |
| Corium, LLC | $27.28 | 2025 | Azstarys |
| Innovation Technologies INC | $24.47 | 2025 | Irrisept |
| Althera Pharmaceuticals LLC | $22.71 | 2021 | |
| Dynavax Technologies Corporation | $22.24 | 2023 | Heplisav-B |
| Pacira Pharmaceuticals Incorporated | $21.81 | 2022 | |
| Kci USA, INC. | $20.12 | 2023 | Activ.A.C. |
| Echosens North America, INC. | $19.11 | 2024 | Fibroscan |
| Tris Pharma INC | $18.18 | 2022 | |
| Seqirus USA INC | $17.40 | 2025 | Flucelvax, Fluad |
| Biotissue Holdings INC. | $15.92 | 2021 | |
| Nevro Corp. | $15.35 | 2024 | Senza |
| Genentech USA, INC. | $15.07 | 2019 | |
| Amgen INC. | $14.48 | 2025 | Krystexxa |
| Depuy Synthes Sales INC. | $13.53 | 2021 | |
| Kuros Biosciences USA, INC | $12.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Pajouh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.